Bragança J, Pinto R, Silva B, Marques N, Leitão HS, Fernandes MT – Charting the path: navigating embryonic development to potentially safeguard against congenital heart defects – J. Pers. Med. (2023), 13, 1263.

​

Correia CD, Ferreira A, Fernandes MT, Silva BM, Esteves F, Leitão HL, Bragança J and Calado SM - Human Stem Cells for cardiac disease modeling and (pre)clinical applications – are we on the road to success? – Cells (2023), 12, 1727.

​

Apolónio JD, Dias JS, Fernandes MT, Komosa M, Lipman T, Zhang CH, Leão R, Lee D, Nunes NM, Maia AT, Morera JL, Vicioso L, Tabori U, Castelo-Branco P - THOR is a targetable epigenetic biomarker with clinical implications in breast cancer - Clin. Epigenetics (2022) 14, 178.

​

Catarino TA, Pacheco-Leyva I, Al-Dalali F, Ghezzo MN, Fernandes MT, Costa T, Dos Santos NR - Cdkn2a inactivation promotes malignant transformation of mouse immature thymocytes before the β-selection checkpoint - Exp. Hematol. (2022) 11630-36.

 

Malho Guedes A, Calças Marques R, Ribeiro B, Fernandes MT, Faísca M, Silva AP, Bragança J, Rodrigues A – Peritoneal protein loss, inflammation and nutrition: refuting myths – Front. Med. (2022) 9, Article 884061.

 

Fernandes MT, Yassuda V, Bragança J, Link W, Ferreira BI, De Sousa-Coelho Al – Tribbles gene expression profiles in colorectal cancer – Gastrointest. Disord. (2021) 3, 218-236.

​

Fernandes MT, Calado SM, Mendes-Silva L and Bragança J – CITED2 and the modulation of the hypoxic response in cancer – World J. Clin. Oncol. (2020) 11, 260-274.

​

Fernandes MT, Caroço LS, Pacheco-Leyva I and Dos Santos N R – NF-κB-dependent RANKL expression in a mouse model of immature T-cell leukemia – Biochem. Biophys. Res. Commun. (2019) 10, 272-277.

​

Ghezzo MN, Fernandes MT, Pacheco-Leyva I, Rodrigues PM, Machado RS, Araújo MSA, Kalathur RK, Futschik ME, Alves NL and Dos Santos N R – FoxN1-dependent thymic epithelial cells promote T-cell leukemia development – Carcinogenesis (2018) 39, 1463-1476.

​

Fernandes MT, Dejardin E and Dos Santos N R – Context-dependent roles for lymphotoxin-β receptor signaling in cancer development – Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2016) 1865, 204-219.

​

Fernandes MT, GHezzo MN, Kalathur RK, Póvoa V, Ribeiro AR, Brandalise SR, Dejardin E, Alves NL, Ghysdael J, Barata J, Yunes JA and Dos Santos N R – Lymphotoxin‐β receptor in microenvironmental cells promotes the development of T‐cell acute lymphoblastic leukaemia with cortical/mature immunophenotype – Br J Haematol​. (2015) 171, 736-751.

​

Boutaffala L, Bertrand MJM, Remouchamps C, Seleznik G, Reisinger F, Janas M, Bénézech C, Fernandes MT , Marchetti S, Mair F, Ganeff C, Hupalowska A, Ricci J-E , Becher B, Piette J, Knolle P, Caamano J, Vandenabeele P, Heikenwalder M and Dejardin E – NIK promotes tissue destruction independently of the alternative NF-κB pathway through TNFR1/RIP1-induced apoptosis – Cell Death Differ. (2015) 22, 2020-2033.

 

Dos Santos NR, Ghezzo MN, Da Silva RC and Fernandes MT – NF-κB in T-cell Acute Lymphoblastic Leukemia: Oncogenic Functions in Leukemic and in Microenvironmental Cells – Cancers (2010) 2, 1838-1860.